Skip navigation
Watchlist Sponsored By :


Current DateTime: 09:55:50 25 Nov 2009
LinksList Documentid: 24355697
  • Runway Angels

      The superbowl of fashion shows, models walk down the runway at the 2009 Victoria's Secret Show.

  • Smartphone Guide

      Here's a need-to-know guide to nine devices, based on features, price, network and platform.

  • Wines for the Holidays

      Not quite sure what wine to pair with Turkey or Creme Brulee? Our experts do.

FEATURED QUIZZES


Current DateTime: 09:55:50 25 Nov 2009
LinksList Documentid: 33793611
  • How Well Do You Know Your Bird?

      Let's talk turkey. Test your turkey knowledge and perhaps pick up a bit of trivia to trot out at your holiday meal.

  • A Healthier & Wealthier You

      Take the following quiz and find out how much you know about the impact of obesity on the health of the U.S. economy.

  • The Billionaire BFF's

      Philanthropists. Bridge partners. Hockey players. Which responses are based on facts from Buffett's and Gates' real lives?


Current DateTime: 09:55:50 25 Nov 2009
LinksList Documentid: 24890560
  • Winterizing Your Portfolio

      If 2009 was the winter of our discontent, will 2010 be a winter wonderland for investors? A lot depends on the recovery—or lack thereof.

  • Investor's Guide to Real Estate

      Some even say the long-awaited recovery is here. Regardless, buyers and sellers alike can profit from our guide.

  • Alternative Investing

      Stocks and bonds? Sure. But it's a big world out there for investors.

powered by digg
European Stocks to Watch: Novartis
By: By CNBC.com | 23 Apr 2007 | 05:16 AM ET
Text Size

Shares of Swiss drugmaker Novartis traded higher (up 0.86%) after the company posted strong sales despite problems with the U.S. food and drug administration.

The company reported on Monday an 11% rise in first-quarter net profit to $2.171 billion driven by strong sales of its flagship drugs, the hypertension drug Diovan and the leukemia drug Gleevec.

Sales of Diovan rose 23% to $1.15 billion and Gleevec sales rose 21% to $674 million.

The company also confirmed its recently revised sales outlook, saying it expects revenue to increase at least 5% this year.

Scottish & Newcastle (up 3.94%) SAB Miller has allied with Diageo to bid for U.K. brewer Scottish & Newcastle with a view to splitting the business in two.

Nestle (up 1.19%) The Swiss company posted a better than expected jump in sales and confirmed its outlook for the full year despite a big jump in raw material prices.

MTU Aero Engines (up 2.43%) The Company reported on Monday that first-quarter underlying profit rose 32% due to strong growth at its original equipment business, and reiterated its profit forecast for the full year.

Societe Generale (down 2.40%) Shares fell back after the French bank denied it was in merger talks with Italian bank Unicredit.

© 2009 CNBC.com
Tools:
Print EmailAdd This share icon
  • digg share

CNBC HIGHLIGHTS

  • For nearly three decades, these on-call experts have been dishing advice on how to – and not to – cook turkey.
  • Eric Schmidt pledges to create a virtual copy of the Iraq National Museum at Google’s expense.
  • Bill Griffeth is taking a leave of absence from CNBC and Power Lunch for a year. Here's a message from Bill.
  • More shoppers than ever plan to comparison-shop this season. Who will benefit?
  • It may be the most unusual guide to business you'll read.
  • Cut Credit cards
  • How can you get out of debt and back on the road to recovery? Follow these ten steps.
ADD COMMENTS
Remaining characters


Current DateTime: 12:56:54 25 Nov 2009
LinksList Documentid: 29778428

Current DateTime: 10:38:04 25 Nov 2009
LinksList Documentid: 29779196

Current DateTime: 04:32:23 25 Nov 2009
LinksList Documentid: 29779199

Current DateTime: 10:38:10 25 Nov 2009
LinksList Documentid: 29779198
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2009 CNBC, Inc.  All Rights Reserved.
A Division of NBC Universal
Thomson ReutersThomson Reuters